Vireo Growth Announces Conference Attendance for September 2026

Vireo Growth will meet investors at a New York life sciences conference, supported by an updated Q2 2026 investor presentation online.

Rhea-AI Summary

Vireo Growth (VREOD, VREOF) plans to attend the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference on September 9, 2026, in New York City.

Chief Financial Officer Tyson Macdonald will hold one-on-one meetings with investors. The company’s current Q2 2026 investor presentation is available on its investor relations website.

Argus Sep 3 session

+0.46% close to close Open Argus

Details

News Market Reaction – VREOF

In the Sep 3 session, VREOF gained 0.46%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Vireo's August 21 acquisition announcement had a 0.2% 24-hour reaction, offering a relevant recent c...

Analysis

Vireo's August 21 acquisition announcement had a 0.2% 24-hour reaction, offering a relevant recent comparison. The conference notice added scheduling information only; investors could watch for new metrics or transaction disclosures at the meeting.

Key Figures

Conference date: September 9, 2026 Presentation period: Q2 2026

Conference date

September 9, 2026

ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference

Presentation period

Q2 2026

Current investor presentation

Historical Context

5 past events · Latest: Aug 21

5 events

1. Aug 21

   Acquisition completion

   24h Move

   +0.2%

   Completed C21 acquisition and expanded Nevada dispensary and cultivation footprint.

2. Aug 13

   Share buyback

   24h Move

   -3.1%

   Authorized repurchases of up to 2,426,872 subordinate voting shares.

3. Aug 11

   Quarterly earnings

   24h Move

   +3.8%

   Reported Q2 revenue growth, gross-profit expansion and adjusted EBITDA.

4. Aug 07

   Credit facility

   24h Move

   +2.5%

   Announced a senior secured revolving credit facility with expandable commitments.

5. Aug 07

   Acquisition completion

   24h Move

   +2.5%

   Completed PharmaCann Colorado asset acquisition and added 17 dispensaries.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), a leading vertically integrated cannabis company and agricultural markets platform, today announced that it will attend the following conference:

ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference
Chief Financial Officer, Tyson Macdonald, will participate in investor one-on-one meetings.
DATE: September 9, 2026
LOCATION: New York City, NY

Vireo’s current Q2 2026 investor presentation is available on the Company’s investor relations website at: https://investors.vireogrowth.com/events-and-presentations

About Vireo Growth Inc.

Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) is a leading vertically integrated cannabis company building a broad platform across cannabis and adjacent agricultural markets. The Company operates cultivation, manufacturing, retail dispensaries, home delivery, distribution, and agricultural supply businesses across the United States, creating exposure to both cannabis and complementary adjacent markets. With operations in 10 states and more than 170 dispensaries nationwide, Vireo combines disciplined capital allocation, strategic acquisitions, and local market execution to scale its platform and drive long-term shareholder value. The Company is focused on expanding market share and strengthening its portfolio of consumer brands and services, while supporting the customers, employees, shareholders, and communities it serves. For more information about Vireo, visit www.vireogrowth.com.

Contact Information:

Lynn Ricci
Director Investor Relations & Corporate Communications
investor@vireogrowth.com 
(781) 956-7052

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Vireo Growth (VREOD) attend the ATB Cormark life sciences conference?

Vireo Growth is scheduled to attend the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference on September 9, 2026, in New York City, NY. The company’s Chief Financial Officer will participate in one-on-one investor meetings.

Who will represent Vireo Growth (VREOD) at the September 2026 investor conference?

Vireo Growth will be represented by its Chief Financial Officer, Tyson Macdonald, who will participate in one-on-one meetings with investors during the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference.

Where can investors find Vireo Growth’s Q2 2026 presentation mentioned in the conference announcement?

Investors can access Vireo Growth’s current Q2 2026 investor presentation on the company’s investor relations website at https://investors.vireogrowth.com/events-and-presentations, which is highlighted in connection with the September 2026 conference attendance.

What type of investor meetings will Vireo Growth (VREOF) hold at the September 2026 conference?

At the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference, Vireo Growth’s Chief Financial Officer, Tyson Macdonald, will participate in one-on-one meetings with investors, offering direct engagement opportunities with the company’s management.